Accelerating and de-risking the discovery of breakthrough medicines for complex neurological disorders.

BrainStorm Therapeutics is a San Diego-based biotechnology company dedicated to transforming central nervous system (CNS) drug discovery, especially for rare genetic and neurodegenerative brain disorders. The company develops an NSF-funded, NVIDIA-award-winning human brain organoid platform that leverages experimental biology and computational approaches (including AI-powered models) to rapidly discover and validate therapies for brain diseases. Their technology focuses on patient-derived stem cell models to probe disease mechanisms and identify promising drug candidates, with a strong commitment to translating these findings into effective medicines for conditions such as Parkinson’s disease, Rett syndrome, schizophrenia, and addiction, among others.

The platform holds promise for addressing both rare and common brain diseases more efficiently and economically than traditional models.

brainstormtherapeutics.org